Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments
Synthesis · 15.11.2024 · 56 (22) · 3450-3458
DOI: 10.1055/s-0040-1720137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 15.11.2024. Verfasst von Quentin Lefebvre und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Target-first drug discovery relies heavily on protein structure information, which severely limits its application. In recent years, fragment-based drug Design (FBDD) has been identified as an alternative solution, where screening of smaller molecules for lower affinity allowed the use of focused libraries with a higher hit rate. It is shown that coupling an sp2-rich heteroaromatic group with a monofunctional sp3-rich core gives fragments (186 examples) with advantageous physical-chemical properties, covering a chemical space often neglected in traditional libraries.
Zitieren
APA
Lefebvre, Q., Mato, R., & Bournez, C. (2024). Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments. Synthesis, 56(22), 3450-3458. https://doi.org/10.1055/s-0040-1720137
Vancouver
Lefebvre Q, Mato R, Bournez C. Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments. Synthesis. 2024;56(22):3450-3458. doi:10.1055/s-0040-1720137
BibTeX
@article{Lefebvre2024,
author = {Lefebvre, Quentin and Mato, Raquel and Bournez, Colin},
title = {Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments},
journal = {Synthesis},
year = {2024},
volume = {56},
number = {22},
pages = {3450--3458},
doi = {10.1055/s-0040-1720137}
}
EUVIMED